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A polyherbal formulation Nila Vembu Kudineer (NVK) is traditionally used in the Siddha medicine to treat variety of 
fevers and related illness. This preparation is also claimed to be useful in the treatment of Dengue and Chickungunya. 
However, information on its safety and effect on vital organs on prolonged consumption is still lacking. Hence, an attempt 
had been made to evaluate the safety profile of NVK by investigating its effect on hematology, biochemistry, antioxidant 
status and histopathology of vital organs of Wistar rats. Three groups of rats (n=4) were considered for the study. Group I 
rats served as control that received only food and water. Group II and III rats were orally administered with freshly prepared 
NVK decoction at400 and 800 mg/kg body weight respectively for 28 consecutive days. The body weights were monitored 
daily and on day 29, overnight fasted animals were sacrificed and the blood was collected to study hematological profile, 
hepato-renalmarkers and antioxidant parameters. The tissues of liver and kidney were subjected to histopathological 
examination. Sub-chronic administration of NVK in lower dose to rats did not produce any significant changes in body and 
organ weights. The hematological parameters as well as hepatic and renaltoxicity markers also showed no significant 
changes in lower dose. However, with higher dose of NVK, mild sinusoidal congestion and dilatation were noticed in liver 
tissues while significant elevation of urea in the serum and hydrophic changes in kidney architecture was observed in 
tissues. The results of the study indicated safety of NVK in the lower dose and possibility of nephrotoxicity with increase in 
dosage and duration.   
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Siddha medicine is one of the oldest traditional 
medical systems widely practiced in Southern India 
and parts of Sri Lanka, Malaysia and Singapore. A 
variety of single and polyherbal formulations are used 
in the system to treat many diseases. Nila Vembu 
Kudineer (NVK), a polyherbal formulation of Siddha 
medicine is prescribed in the treatment of many types 
of fevers especially of unknown origin1. It is advised 
in Siddha medicine to consume about 25 mL of the 
decoction (obtained by boiling 3.6 g of the 
formulation in 25 mL of water), thrice a day for three 
consecutive days. During the outbreak of Dengue and 
Chickungunya, the Government of Tamil Naduhas 
popularized NVK as a preventive measure in the last 
few years2,3. The decoction of NVK is freely 
distributed to the public in all hospitals and rural 
health centers especially to those who reside in 
epidemic zones to control morbidity and mortality4,5. 
The use of NVK in controlling viral fevers has also 
been incorporated in the Health Policy Note of the 
State Government6.  
However, there are apprehensions on NVK’s safety 
due to lack of toxicological profile7. Hence, in this 
study, the effect of the drug on sub-chronic 
administration in Wistar rats had been carried out by 
investigating changes in hematology, biochemistry, 
LPO, antioxidant enzymes and histopathology of liver 
and kidney tissues.  
 
Materials and methods 
Animals 
Twelve Wistar rats of either sex weighing about 
180+10 g and housed in controlled environmental 
conditions (temperature: 24+2oC, relative humidity: 
50-70% and 12 h light/dark cycle) were used in this –——— *Corresponding author 
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study. The animals were provided with standard pellet 
diet and water ad libitum. The experiments were 
performed as per the guidelines of Committee for the 
Purpose of Control and Supervision of Experiments 
on Animals, after obtaining necessary permission 
from the Institutional Animal Ethics Committee 
(Approval No: BRULAC/SDCH/SIMATS/IAEC/02-
2018/006) 
 
Drug preparation 
NVKwas obtained from Tamil Nadu Medical Plant 
Farms and Herbal Medicine Corporation Limited 
(TAMPCOL), Chennai, Tamil Nadu, India. The 
polyherbal formulation consists of dry powders of the 
following plants in equal proportions – Andrographis 
paniculata (Burm. f.) Wall. Ex Nees. (Whole plant), 
Plectranthus vettiveroides (Jacob) Singh & Sharma 
(roots), Vetiveria zizanioides L. Nash (roots), Zingiber 
officinale Roscoe.(rhizomes), Piper nigrum L. (fruits), 
Cyperus rotundus L. (tubers), Santalum album L. 
(heart wood), Trichosanthes cucumerina L. (whole 
plant) and Hedyotis corymbosa L. Lam (whole 
plant)8. The decoction for administration to the 
animals was prepared daily by boiling 3.6 g of NVK 
with 25 mL of water (The weight of the drug used 
was calculated on the basis of human dose that is 
equal to two table spoons of the dry formulation in 
200 mL water). The contents were cooled to room 
temperature, filtered and administered to animals by 
oral gavages. 
 
Experimental design 
Twelve rats were divided into three groups each 
containing four animals. Group I rats served as 
control that received only food and water while 
Groups II and III rats were administered with 400 and 
800 mg/kg body weight of NVK decoction 
respectively. The doses were selected based on the 
earlier report9. The treatment was continued for 28 
consecutive days and on day 29, overnight fasted 
animals were anaesthetized and sacrificed after 
cervical dislocation and blood was collected for 
hematological, biochemical and antioxidant 
investigations10-12. The liver and kidney were quickly 
removed, washed with normal saline and used for 
histopathological studies.  
 
Results 
Administration of NVK to animals in lower dose 
(400 mg/kg b. w.) for 28 days did not reveal any 
perceptible changes in behavior, body and organ 
weights, hematological parameters and biochemical 
markers. Aspartate aminotransferase (AST), alkaline 
phosphatase (ALP), gamma-glutamyltransferase  
(γ-GT) and bilirubin did not show any significant 
changes after NVK administration (Fig. 1A, C, D, E). 
However, with higher dose, significant (p<0.05) 
changes were observed inalanine aminotransferase 
(ALT) (Fig. 1B) and urea content (Fig. 1F). In the 
oxidative stress markers, lipid peroxidation (LPO) 
showed significant (p<0.001) reduction with 
concomitant increase (p<0.001) in superoxide 
dismutase (SOD) activity and catalase showed a 
significant (p<0.01) increase only with lower dose of 
NVK administration (Fig. 2). In the histopathological 
investigations, in higher dose group, sinusoidal 
congestion and dilatation in liver and hydrophic 
changes in kidney tissues were noticed (Fig. 3). 
 
Discussion 
Dengue and Chickungunya fevers are caused by 
re-emergent arbo-viruses that are transmitted by 
mosquitoes of Ades genus. These viruses, over the 
 
Fig. 1 — NilaVembuKudineer (NVK)-induced changes in 
hepatotoxic and nephrotoxicitymarkers. Values represent 
Mean ± S.D of four values; *p<0.05 vs control. AST: Aspartate
aminotransferase; ALT: Alanine aminotransferase; ALP: Alkaline
phosphatase; γ-GT: Gamma glutamyltransferase; TB: Total
bilirubin; DB: Direct bilirubin; IDB: Indirect bilirubin. 
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years, were responsible for thousands of deaths 
every year worldwide. The incidence of Dengue 
infection has increased nearly thirty folds in the past 
fifty years. Approximately 50-100 million new 
infections are reported to occur annually in more 
than hundred endemic countries and also further 
spread to areas that were earlier unaffected resulting 
in about 20,000 deaths13. Chickungunya fever was 
first reported in 1952 along the borders of Tanzania 
and Mozambique14,15. In 2006, the virus was 
responsible for an epidemic for unprecedented 
magnitude in Indian Ocean countries16. In this 
scenario, new therapeutic approaches are needed to 
check these incidents with cost-effective and readily 
available natural materials. The traditional medical 
systems that are practiced in many countries are 
explored of late to overcome such maladies. India is 
blessed with age old medical practices such as 
Ayurveda, Siddha and Unani besides Homoeopathy 
and folklore medicines.  
In Siddha system of medicine, many formulations 
of single and polyherbal combinations are extensively 
employed to treat diseases. NVK is one such 
polyherbal formulation that is prescribed in the 
treatment of a variety of fevers. In the recent years, it 
has been tried as a prophylactic measure during the 
outbreak of Dengue and Chikungunya in Tamil Nadu 
State2,3. As there is no scientific validation available 
on date on its toxicological profile, the present study 
has been undertaken in rat model. Sub-chronic 
  
Fig. 2 — NilaVembuKudineer (NVK)-induced changes in oxidative stress markers. Values represent Mean ± S.D of four values; **p<0.01 
and ***p<0.001 vs control. MDA: Malondialdehyde; SOD: Superoxide dismutase; CAT: Catalase 
 
  
Fig. 3 — Histopathology of Liver and Kidney tissues; (a): Control; (b) NVK: 400 mg (c) NVK: 400 mgCV: Central vein; SS: Sinusoidal
space; G: Glomerulus; RT: Renal tubules; HD: Hydropic degeneration; PCT and DCT: Proximal and Distal Convoluted Tubule 
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administration of NVK to the animals did not change 
their body and organ weights as well as hematology, 
hepatic and renal parameters in lower dose. However, 
with higher dose, mild sinusoidal congestion and 
dilatation were noticed in liver tissues. It also caused 
significant elevation of urea in the serum with 
hydropic changes in kidney architecture. 
Liver and kidney are detoxifying organs and the 
enzymatic changes occur in them are revealed in their 
parameters (AST, ALT, ALP, bilirubin, γ-GT, urea 
and creatinine). The toxic substances that induce lipid 
peroxidation through oxidative stress are supposed to 
be responsible for such changes. The enzyme γ-GT is 
found in many organs throughout the body, with 
highest concentrations in liver17. Its biological role is 
to reconstitute glutathione (GSH), which is the main 
intracellular antioxidant. When the concentration of γ-
GT goes above normal level, it catabolizes the non-
enzymatic GSH leading to its depletion18. The 
increased SOD and catalase activities observed in the 
study suggested that these enzymes might have a 
major role in the inhibition of LPO. Hence the level of 
MDA was reduced probably due to increase in 
scavenging rate of free radicals and thus enhancing 
non-enzymatic defences19. With respect to renal 
markers, creatinine did not show any significant 
alteration in both doses of NVK. However, a 
significant increase in urea level has been observed in 
high dose of NVK treatment suggesting a possible 
adverse effect on long term administration of this 
formulation.  
 Histopathological changes in liver showed mild 
sinusoidal congestion and dilatation with higher dose 
group of animals while the kidney revealed hydrophic 
degeneration-like changes and loss of tubular 
architecture. Andrographolide, a constituent of 
Andrographis paniculata, has been reported to cause 
acute kidney injury20. The latter is one of the 
ingredients of NVK formulation. The increase in urea 
level at higher dose of NVK lends support to this 
observation. However, further studies are warranted 
to substantiate this. 
 
Conclusion 
On the basis of observed results, it is concluded 
that NVK had no adverse effect on biochemical 
parameters and tissues of liver and kidney at lower 
dose suggesting that the drug might be consumed 
following dose and duration restrictions as mentioned 
in the classical Siddha literature. 
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